HOME >> MEDICINE >> NEWS
Georgia Tech researchers developing biomechanic device to grow arteries for bypass surgery patients

Biomedical engineers at the Georgia Institute of Technology (Georgia Tech) are testing a device that, when implanted, mechanically lengthens an existing artery in patients preparing for coronary artery bypass surgery (CABG). The lengthened artery, when harvested and used as a graft, has the potential to greatly improve the long-term outcomes of bypass patients.

Designed to stimulate growth in the gastroepiploic artery a small, disease-free artery about 3-7 mm diameters in size and located below the stomach the device has shown to be effective in lengthening arterial tissue in pigs by as much as 30 cm enough for a patient to undergo at least two CABG procedures, researchers say.

The patented process has been coined "distraction angiogenesis" by lead scientist Ray Vito, a professor at Georgia Tech who holds dual appointments in the Woodruff School of Mechanical Engineering and the Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

Vito is president and CEO of Medanoia Medical Inc., a company he formed in February 2001, along with Jack Griffis, COO, to develop, manufacture and market the device. The process is similar to distraction osteogenesis a process that has been used clinically since the 1950's to lengthen bones, especially in the legs and face.

"The long-term outcome of coronary bypass surgery is critically dependent on the graft that is used," Vito said. "The consensus among surgeons and cardiologists is that arterial grafts are preferable to venous grafts (veins) because they stay open much longer. However, the human body has a very limited supply of arterial tissue that can be harvested without consequence to the patient. Distraction angiogenesis increases the supply of arterial tissue suitable for use as grafts."

Coronary artery bypass surgery is among the most common operations performed in the world to bypass a blockage. Clogged arteries are often caused by a buildup of fat, plaq
'"/>

Contact: Larry Bowie
larry.bowie@icpa.gatech.edu
404-894-6016
Georgia Institute of Technology Research News
31-Oct-2002


Page: 1 2 3

Related medicine news :

1. Georgia Medicaid program saves $20 million by controlling use of anti-ulcer drugs
2. Medical College of Georgia to establish clinical campus at Phoebe Putney Memorial Hospital
3. New study from researchers at University of Georgia suggests condom use sends positive message to partner
4. NSF award to five Georgia universities for new Science and Technology Center
5. Indiana University researchers closer to helping hearing-impaired using stem cells
6. Protein that helps skin cancer spread identified by Stanford researchers
7. US life expectancy about to decline, researchers say
8. Gene for age-related macular degeneration discovered by Yale researchers
9. Dartmouth researchers find where musical memories are stored in the brain
10. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
11. US cancer researchers launch first American-Israeli cancer conference

Post Your Comments:
(Date:5/20/2013)... Heritage Woods of Gurnee , a ... is hosting Breakfast and Bingo at 8:30 a.m. on ... at 3775 Grand Ave. in Gurnee, Illinois, serves older ... need some help to maintain their independence. , "Come ... bingo," says Tammy Temaner-Rosas, Director of Marketing for Heritage ...
(Date:5/20/2013)... MN (PRWEB) May 20, 2013 When a ... bed is only part of the process. Much of the ... the internet involves not knowing what to expect. Best ... advice consumers can use to ensure their purchase proves smooth. ... You Buy a Mattress Online ”, readers find helpful tips ...
(Date:5/20/2013)... 2013 Fastcare Miami Beach clinic ... within its first symptoms, as if not treated, it may ... serious infection. Although a urinary tract infection in itself is ... serious kidney infection called pyelonephritis. Women seem to have many ... to the same percentage as women after the age of ...
(Date:5/20/2013)... 20, 2013 Eben Pagan's ... the public creating a frenzy among business owners ... elite business training. WealthSpringMarketing.com's Tiffany Hendricks has published ... an exclusive bonus. , "Eben Pagan is a ... training to individuals serious about success," reports Hendricks. ...
(Date:5/20/2013)... May 20, 2013 Leading facial plastic surgeon ... recognized as a “Top Doc” in the field of Otolaryngology ... , The Palm Beacher magazine, one of Palm Beach ... Docs” in the May/June 2013 issue, including 70 of the ... and dining, events, things to do, health and fitness, people ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...
(Date:5/20/2013)... Md. , May 20, 2013  Neuralstem, Inc. ... Feldman , MD, PhD, principal investigator, presented updated ... stem cell (NSI-566) trial in the treatment of amyotrophic ... ,s disease) at the neuro diabetes special medical symposium ... In a talk called "Recent Therapeutic Advances in Stem ...
Breaking Medicine Technology:Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
Cached News: